New depression drug shows promise in early trial
NCT ID NCT06267846
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 28 times
Summary
This study tested an experimental drug called NBI-1070770 in 73 adults with major depressive disorder. The goal was to see if it could safely and quickly improve depression symptoms compared to a placebo. Participants continued their usual antidepressants during the trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neurocrine Clinical Site
Little Rock, Arkansas, 72211, United States
-
Neurocrine Clinical Site
Rogers, Arkansas, 72758, United States
-
Neurocrine Clinical Site
Lemon Grove, California, 91945, United States
-
Neurocrine Clinical Site
Long Beach, California, 90806, United States
-
Neurocrine Clinical Site
Hollywood, Florida, 33024, United States
-
Neurocrine Clinical Site
Maitland, Florida, 32751, United States
-
Neurocrine Clinical Site
Decatur, Georgia, 30030, United States
-
Neurocrine Clinical Site
Savannah, Georgia, 31405, United States
-
Neurocrine Clinical Site
Gaithersburg, Maryland, 20877, United States
-
Neurocrine Clinical Site
Dayton, Ohio, 45439, United States
-
Neurocrine Clinical Site
North Canton, Ohio, 44730, United States
-
Neurocrine Clinical Site
Houston, Texas, 77008, United States
-
Neurocrine Clinical Site
Richardson, Texas, 75080, United States
Conditions
Explore the condition pages connected to this study.